HealthQuill Articles by: HealthQuill
AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.
Drugs Health Pharma

AstraZeneca’s trial breast cancer drug fails to meet primary goals

AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.

Read More
Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.
Drugs Health Pharma

Takeda’s trials for epilepsy treatment fail to meet primary seizure goals

Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.

Read More
he US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria that cause invasive pneumococcal disease.
Drugs Health Pharma

Merck’s vaccine for pneumococcal disease gets FDA’s green light

The US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria

Read More
The US requires a warning label on social media platforms as they are significantly associated with “mental health harms” for adolescents, the United States Surgeon General, Dr Vivek Murthy wrote in an op-ed piece in the New York Times.
Health Medical Pharma

US Surgeon General calls for warning labels on social media platforms

The US requires a warning label on social media platforms as they are significantly associated with “mental health harms” for adolescents, the United

Read More
The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.
Drugs Health Pharma

FDA gives nod for AstraZeneca’s Imfinzi to treat endometrial cancer

The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.

Read More
The size of gray whales found along the Oregon coast in the US has shrunk by 13% in the past 20-30 years — a signal that may indicate that their population is starting to decline, a study shows.
Climate Health Pharma

Gray whales shrink in size by 13%, their numbers may fall: Oregon researchers

The size of gray whales found along the Oregon coast in the US has shrunk by 13% in the past 20-30 years —

Read More
The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took more than 15 months to address a February 2021 Abbott facility whistleblower complaint, according to a federal audit.
Drugs Health Pharma

US audit finds gaps in FDA’s procedures during infant formula crisis

The US drug regulator, FDA, did not have an organizational structure or assigned responsibilities to handle whistleblower complaints “efficiently and effectively” and took

Read More
AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company statement.
Drugs Health Pharma

AstraZeneca’s trial drug for mantle cell lymphoma raises survival rate

AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company

Read More
Pfizer Inc.,’s investigational drug for blood cancer, Elrexfio, has shown an overall survival rate of 24.6 months in a single-arm trial, according to a statement.
Drugs Health Pharma

Pfizer’s blood cancer trial data shows survival of more than 2 years 

Pfizer Inc.,’s investigational drug for blood cancer, Elrexfio, has shown an overall survival rate of 24.6 months in a single-arm trial, according to

Read More
The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and eliminating the disease by 2030 after Covid-19 disrupted its rollout.
Drugs Health Pharma

Vaccine Alliance steps up bid to end rabies by 2030 after Covid-19 pause

The UN’s Gavi, the Vaccine Alliance, has restored its efforts to prevent and control rabies globally by increasing the availability of vaccines and

Read More